Inventor · disambiguated record
Micael Guillot
Also filed as: GUILLOT MICAEL · GUILLOT MICAEL A
5 granted patents·2 pending applications·68 citations·filing 1999–2018
80Inventor score
Files withAPRECIA PHARMACEUTICALS CO3APTALIS PHARMATECH INC1Aprecia Pharmaceuticals LLC1SANOFI AVENTIS US LLC1SANOFI SYNTHELABO1
Top patents by PatentIndex Score
7 records- 0196US9314429B2Rapidly dispersible dosage form of oxcarbazepineAPRECIA PHARMACEUTICALS CO·Filed 2015·Granted Apr 19, 2016·22 cites·14 claims
- 0294US9616018B2Rapidly dispersible dosage form of oxcarbazepineAPRECIA PHARMACEUTICALS CO·Filed 2016·Granted Apr 11, 2017·9 cites·25 claims
- 0384US10028909B2Rapidly dispersible dosage form of oxcarbazepineAPRECIA PHARMACEUTICALS CO·Filed 2017·Granted Jul 24, 2018·2 cites·26 claims
- 0470US7713548B2Amorphous solid dispersionsSANOFI AVENTIS US LLC·Filed 2008·Granted May 11, 2010·1 cites·33 claims
- 0567US6197787B1Pharmaceutical formulations containing poorly soluble drug substancesSANOFI SYNTHELABO·Filed 1999·Granted Mar 6, 2001·34 cites·50 claims
- 0667US2018296479A1Rapidly Dispersible Dosage Form with High Drug ContentAprecia Pharmaceuticals LLC·Filed 2018·Application pending·0 cites
- 0753US2015030676A1Stablized modified release folic acid derivative composition, its therapeutic use and methods of manufactureAPTALIS PHARMATECH INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Micael Guillot files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →